Functional genomics represents a new phase of genome analysis. It
refers to the development and application of global experimental
approaches to assess gene function. It is characterized by high
throughput or large-scale experimental methodologies combined with
statistical and computational analysis of the results. The fundamental
strategy in a functional genomics approach is to expand the scope of
biological investigation from studying single genes or proteins to
studying all genes or proteins at once in a systematic fashion.
Sophisticated statistical and computational techniques are required to
analyze responses of thousands of genes in order to identify
interesting genes or clusters of genes. E.g. by examining the level of
gene expression in cell populations of disease and pre-disease states,
investigators will attempt to understand the steps of disease
development and to identify the genes involved in disease
susceptibility and gene-environment interactions.
The track focuses on new statistical and computational topics in
functional genomics and expression array analysis.
Co-Chairs:
Axel Benner, German Cancer Research Center, Germany.
E-mail: Send
Ramon Diaz-Uriarte, Spanish National Cancer Centre (CNIO), Spain.
E-mail: Send
Wolfgang Huber, EBI/EMBL Cambridge UK.
E-mail: Send
Martina Mittlbock, Medical University of Vienna, Austria.
E-mail: Send
Members
- Adrian Alexa, Max-Planck Institute for Informatics, Saarbruecken,
Germany
- Tim Beissbarth, German Cancer Research Center, Heidelberg,
Germany
- Henrik Bengtsson, Lund University, Sweden
- Axel Benner, German Cancer Research Center, Heidelberg,
Germany
- Paul Bertone, European Bioinformatics Institute, Hinxton, UK
- Elia Biganzoli, University of Milano, Italy
- Anne-Laure Boulesteix, Sylvia Lawry Centre for Multiple Sclerosis
Research, Germany
- Richard Bourgon, European Bioinformatics Institute, Hinxton,
UK
- Benedikt Brors, German Cancer Research Center, Heidelberg,
Germany
- Peter Buehlmann, ETH Zuerich, Switzerland
- Anthony Davison, Ecole Poytechnique Federale de Lausanne,
Switzerland
- Mauro Delorenzi, Swiss Institute of Bioinformatics (SIB),
Lausanne, Switzerland
- Marcel Dettling, Zurich University of Applied Sciences Winterthur,
Switzerland
- Ramon Diaz-Uriarte, Spanish National Cancer Center, Madrid,
Spain
- Martin Dugas, University of Muenster, Germany
- Jelle Goeman, Leiden University Medical Center, Leiden, The
Netherlands
- Darlene Goldstein, Ecole Poytechnique Federale de Lausanne,
Switzerland
- Wolfgang Huber, European Bioinformatics Institute, Hinxton,
UK
- Manuela Hummel, IBE, LMU Munich, Germany
- Dirk Husmeier, Biomathematics & Statistics Scotland, Edinburgh,
UK
- Carina Ittrich, BI Pharma GmbH & Co. KG, Biberach, Germany
- Berthold Lausen, Friedrich-Alexander-University of
Erlangen-Nuremberg, Germany
- Wolfgang Lehrach, University of Edinburgh, UK
- Ulrich Mansmann, IBE, LMU Munich, Germany
- Crispin Miller, Paterson Institute for Cancer Research,
Manchester, UK
- Martina Mittlboeck, Medical University of Vienna, Austria
- Yudi Pawitan, Karolinska Institutet, Stockholm, Sweden
- Alexander Ploner, Karolinska Institutet, Stockholm, Sweden
- Joerg Rahnenfuehrer, University of Dortmund, Germany
- Magnus Rattray, University of Manchester, UK
- Dirk Repsilber, FBN, Dummerstorf, Germany
- Juliane Schaefer, ETH Zuerich, Switzerland
- Rainer Spang, University of Regensburg, Germany
- Korbinian Strimmer, University of Leipzig, Germany
- Simon Tavare, University of Cambridge, UK
- Achim Tresch, Johannes Gutenberg-University Mainz, Germany
- Arndt von Haeseler, Center for Integrative Bioinformatics Vienna,
Austria
- Anja von Heydebreck, MERCK KGaA, Darmstadt, Germany
- Marc Weimer, German Cancer Research Center, Heidelberg,
Germany
- Wiebke Werft, German Cancer Research Center, Heidelberg,
Germany
Created by Computing & Statistics Working Group
2007
|